Peptide profile · Weight Management
Tirzepatide
The dual-action powerhouse that targets both GIP and GLP-1 receptors, delivering the most dramatic weight loss results ever seen in a medication—averaging over 20% body weight reduction while also crushing blood sugar levels in people with diabetes.
Written by Michael Carroll — Owner, Director of Research · Reviewed by the Peptide Initiative Research Team
Dose timeline
2.5 mg
First 4 weeks
5-10 mg
Increase by 2.5 mg after at least 4 weeks at each dose
12.5-15 mg
Ongoing maintenance
Half-life
Approximately 5 days (120 hours)
Bioavailability
~80% (subcutaneous)
Molecular weight
4813.45 g/mol
Evidence level
Strong human trials
01 · Compound profile
Scientific & efficacy data
Molecular formula
C225H348N48O68
Primary benefits
Produces 20%+ average body weight loss at the highest dose—the most effective weight loss medication ever approved, approaching surgical results
Dual GIP/GLP-1 activation creates powerful, sustained appetite suppression that makes portion control feel effortless rather than a constant battle
Outperformed semaglutide head-to-head for diabetes management, with HbA1c reductions exceeding 2 percentage points in clinical trials
Eli Lilly and Company
Amino acid sequence
Tyr-Aib-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Ile-Aib-Leu-Asp-Lys-Ile-Ala-Gln-Lys(C20 fatty diacid-γGlu-2xOEG)-Ala-Phe-Val-Gln-Trp-Leu-Ile-Ala-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-NH202 · Dosing
How much do I take?
2.5 mg, titrated to 5-10 mg · once weekly
Subcutaneous injection: A small injection into the fatty layer just under the skin — the same way insulin is given.
Bioavailability High — most of the dose reaches your bloodstream, just more gradually than an IV.
Best time to take
Pick any day of the week that works for you and stick with it. Many people choose a weekend day so they can rest if they experience mild nausea. The exact time of day doesn't matter much thanks to the long half-life—just be consistent.
With food?
Tirzepatide injections can be taken with or without food—it won't affect how the medication works. However, because it slows stomach emptying significantly, eating smaller meals will help you avoid nausea and discomfort. Avoid large, fatty meals.
If stacking
Tirzepatide is typically used as a standalone weight management therapy. If you have diabetes and take insulin or sulfonylureas, those doses will likely need to be reduced to prevent low blood sugar. Always coordinate with your healthcare provider before combining medications.
＋ Increase if
- +You've tolerated the current dose for 4+ weeks without significant GI problems
- +Weight loss has slowed or plateaued and you haven't reached the maximum dose
- +Blood sugar targets aren't being met (for diabetes patients)
- +Your healthcare provider recommends continuing the titration schedule
－ Decrease if
- −Nausea, vomiting, or diarrhea are severe and don't improve after a few weeks
- −You're unable to eat enough to maintain basic nutrition
- −You experience signs of dehydration from persistent GI symptoms
- −Side effects significantly impact your daily life and functioning
✓ Signs of right dose
- ✓Steady weight loss of 1-2+ pounds per week
- ✓Feeling genuinely satisfied with smaller portions
- ✓Reduced food cravings and less thinking about food
- ✓Minimal or manageable GI side effects
Dosing Calculator
Calculate Your Exact Dose
Step 1: Peptide Weight
Find the weight printed on your peptide vial label
Look here!
The peptide weight is printed on the label
Look here!
The weight is on the label
Select Weight
Look for a number followed by 'mg' on the vial label (e.g., 5mg, 10mg)
03 · Suitability
Is this right for me?
Best for maximum weight loss results & long-term obesity management
Best for
People Who Want Maximum Weight Loss Results
If you're serious about losing significant weight, tirzepatide delivers results that were previously only achievable through bariatric surgery. Clinical trials showed average weight loss exceeding 20% of body weight—that's 50+ pounds for someone starting at 250 pounds. No other medication comes close.
Those Who Haven't Succeeded with Semaglutide
Thanks to its dual GIP/GLP-1 mechanism, tirzepatide often works better for people who had limited results with GLP-1-only drugs like semaglutide. The added GIP activation provides extra metabolic benefits that can break through plateaus and deliver superior weight loss.
People with Type 2 Diabetes Needing Aggressive Control
Head-to-head trials proved tirzepatide beats semaglutide for blood sugar control. The average HbA1c reduction of over 2 percentage points means many people can dramatically reduce or eliminate other diabetes medications. It's a genuine game-changer for metabolic health.
Individuals Looking to Transform Their Relationship with Food
Tirzepatide doesn't just reduce hunger—it fundamentally changes how food appeals to you. Users describe feeling free from constant food thoughts, finding it easy to stop eating when satisfied, and losing interest in formerly irresistible treats. It's not willpower—it's biochemistry working for you.
Consider alternatives if
Do not use if
Use with caution if
Not sure?
Compare Tirzepatide with similar peptides to find the best fit for your goals.
04 · Administration
How do I use it?
Subcutaneous injection
Reconstitution — what you need
Example
Tirzepatide comes in pre-filled, single-dose pens at specific strengths: 2.5mg, 5mg, 7.5mg, 10mg, 12.5mg, and 15mg. Each pen contains exactly one dose—no calculations or dose selection needed. Simply use the entire pen contents for your weekly injection.
Each pen is designed for single use at its labeled dose. For example, a 5mg pen delivers exactly 5mg when fully administered. The pen mechanism ensures you receive the complete dose. Use one pen per week at your prescribed strength.
Route
Subcutaneous injection (into the fatty tissue just under the skin)—the pen makes it quick and virtually painless, and you can easily do it yourself at home
Best sites
Technique
- 01Remove pen cap and check the medicine window—solution should be clear and colorless
- 02Clean your injection site with an alcohol swab and let it air dry completely
- 03Remove the base cap to reveal the needle (it's hidden until you're ready)
- 04Press the pen firmly against your skin at a 90-degree angle
- 05Press and hold the purple injection button until you hear two clicks
- 06Keep the pen pressed against your skin until the gray plunger is visible (about 5-10 seconds)
- 07Remove the pen and dispose of the entire pen in a sharps container—each pen is single-use
Storage · before reconstitution
Store new, unopened pens in the refrigerator at 36-46°F (2-8°C). Never freeze tirzepatide—freezing destroys the medication. Keep pens in the original carton to protect from light. If needed, unopened pens can be stored at room temperature (up to 86°F/30°C) for up to 21 days.
Storage · after reconstitution
Tirzepatide pens are single-use and do not require reconstitution. Once you use a pen, dispose of it properly in a sharps container. Never reuse pens or attempt to get multiple doses from one pen.
Signs of degradation
Sample daily schedule
05 · Safety
Is it safe?
4 common side effects · 3 serious
Tirzepatide has been extensively studied in the SURPASS (diabetes) and SURMOUNT (obesity) trial programs, involving thousands of participants over multiple years. The FDA approved it after thorough safety review. While GI side effects are common (especially during dose increases), they're typically mild to moderate and improve over time. Serious adverse events are rare. The SURPASS-CVOT trial is ongoing to evaluate long-term cardiovascular outcomes.
Safety data comes from multiple Phase 3 trials with follow-up extending beyond 72 weeks. The overall safety profile is similar to GLP-1-only medications like semaglutide, with GI symptoms being the most frequent issues. The thyroid tumor risk seen in rodents has not been confirmed in humans, but remains a theoretical concern requiring ongoing monitoring.
Common side effects · experienced by some users
Less common
These typically resolve with continued use or dose adjustment.
Stop and seek help if
- ×Severe or persistent GI symptoms that prevent adequate nutrition despite dose adjustments and supportive care
- ×Signs of pancreatitis—severe abdominal pain radiating to the back requiring emergency evaluation
- ×Allergic reaction—rash, hives, itching, facial swelling, or difficulty breathing
- ×Signs of thyroid problems—neck lump, persistent hoarseness, difficulty swallowing
- ×Pregnancy or planning to become pregnant (stop at least 1 month before attempting conception)
- ×Severe kidney problems or persistent dehydration from GI symptoms
- ×Your healthcare provider recommends discontinuation for any reason
Tirzepatide is a prescription medication that should only be started, adjusted, or stopped under medical supervision. This information is for education only and does not replace professional medical advice. While stopping tirzepatide abruptly is generally safe, discuss any changes with your healthcare provider. Weight regain is common after discontinuation.
With other peptides
- !Semaglutide and other GLP-1 agonists — Never combine GLP-1 medications—they work through overlapping mechanisms. Combining would dramatically increase side effects without additional benefit.
- ✓BPC-157 — No direct interaction data exists. BPC-157 is sometimes used for gut healing which could theoretically help with GI side effects, but this is speculative and unstudied.
- ✓Growth Hormone Peptides — Limited interaction data available. Both can affect glucose metabolism, so combining should only be done under close medical supervision.
With medications
- !Insulin — Tirzepatide dramatically enhances insulin's blood sugar-lowering effect. Insulin doses typically need reduction of 20-50% or more when starting tirzepatide to prevent dangerous hypoglycemia. Close monitoring essential.
- !Sulfonylureas (glipizide, glyburide, glimepiride) — High hypoglycemia risk when combined. Sulfonylurea doses usually need significant reduction. Monitor blood sugar frequently and watch for symptoms of low blood sugar.
- ✓Oral Contraceptives — Tirzepatide's effect on gastric emptying may alter absorption of oral medications. Consider using alternative or backup contraception, especially during dose changes.
- ✓Warfarin — May affect warfarin absorption and metabolism. Increased INR monitoring recommended when starting tirzepatide or changing doses.
- ✓Acetaminophen and other oral medications — Significantly delayed gastric emptying may slow absorption of oral medications. Consider timing and discuss with your pharmacist.
With supplements
- ✓Vitamin B12 — Long-term use of incretin medications may reduce B12 absorption. Consider B12 supplementation, especially if you've been on tirzepatide for over a year.
- ✓Fiber Supplements — Can help manage constipation but start slowly—too much fiber too fast can worsen GI symptoms. Psyllium husk is a gentle option.
- ✓Protein Supplements — Highly recommended to preserve muscle mass during rapid weight loss. Aim for 1g protein per pound of goal body weight, or at least 60-80g daily.
- ✓Electrolyte Supplements — Helpful if experiencing diarrhea or vomiting to prevent dehydration and electrolyte imbalances.
06 · Effectiveness
How do I know it's working?
Strong human trials · first signs weeks 1-4 (2.5mg dose)
Evidence level
Strong human trials
(Phase 3 or FDA approved)
How it works
Your body has two 'fullness hormones' that tell your brain when you've eaten enough: GLP-1 and GIP. Regular weight loss drugs only mimic one of these. Tirzepatide is special because it copies both hormones at once—like having two keys to unlock the same door. This dual action sends an extra-strong 'I'm satisfied' signal to your brain, making you naturally want to eat much less. It also slows down how fast food leaves your stomach, so small meals keep you full for hours. The result? You lose weight because your biology is finally working with you instead of against you, and hunger stops being something you have to constantly fight.
Tirzepatide is a 39-amino acid synthetic peptide that acts as a dual GIP/GLP-1 receptor agonist, with GIP activity being the more potent of the two (approximately 5:1 GIP:GLP-1 affinity ratio). The molecule incorporates key modifications for extended half-life: an aminoisobutyric acid (Aib) substitution at position 2 for DPP-4 resistance, and a C20 fatty diacid chain attached via a glutamic acid spacer at Lys20 for albumin binding. This yields a half-life of approximately 5 days, enabling once-weekly dosing. Mechanistically, GLP-1 receptor activation in hypothalamic neurons (particularly POMC/CART and NPY/AgRP pathways) reduces appetite and food reward. GIP receptor activation appears to enhance these central effects while also improving insulin sensitivity and potentially facilitating adipose tissue metabolism. In pancreatic beta cells, both pathways potentiate glucose-dependent insulin secretion while suppressing glucagon from alpha cells. The combination produces synergistic effects on weight loss and glycemic control exceeding what either pathway achieves alone. Gastric emptying is substantially delayed (more so than with GLP-1 agonists alone), contributing to prolonged satiety.
What to expect
Weeks 1-4 (2.5mg dose)
What you might notice
- •Mild nausea, especially after eating larger meals
- •Possibly feeling slightly fuller than usual
- •Minimal to no weight loss yet—this is normal and expected
- •Some people feel almost nothing at this dose—that's completely fine
What's normal
- •GI symptoms that come and go throughout the day
- •Still feeling hungry between meals
- •Weight staying about the same or losing just 1-2 pounds
- •Getting comfortable with your weekly injection routine
What's next
- →After 4 weeks, increase to 5mg
- →Continue eating normally—don't force dietary changes yet
- →Establish your consistent weekly injection day
Weeks 5-16 (5-10mg doses)
What you might notice
- •Noticeably reduced appetite and less thinking about food
- •Feeling genuinely satisfied with smaller portions
- •Weight loss becoming visible—typically 5-10% of starting weight
- •GI side effects may briefly intensify with each dose increase, then improve
What's normal
- •Temporary nausea for a few days after each dose increase
- •Smaller meals feeling completely satisfying
- •Significant reduction in food cravings and snacking urges
- •Clothes starting to fit differently
What's next
- →Continue gradual dose increases every 4 weeks (5mg → 7.5mg → 10mg)
- →Prioritize protein at every meal to preserve muscle
- →Start noticing how your relationship with food is fundamentally changing
Weeks 17-28 (12.5-15mg doses)
What you might notice
- •Powerful appetite suppression—you may need reminders to eat
- •Steady, significant weight loss of 2+ pounds per week
- •Food cravings dramatically reduced or absent
- •GI symptoms typically stabilizing by now
What's normal
- •Eating 30-50% less than before starting, without feeling deprived
- •Much less interest in formerly irresistible foods
- •Visible physical transformation—face, waist, body composition
- •Improved energy and mobility as weight comes off
What's next
- →Reach the 15mg maximum dose or find your optimal maintenance level
- →Focus on building sustainable long-term eating patterns
- →Incorporate regular physical activity as you feel more energetic
Months 7-12 and beyond
What you might notice
- •Approaching or exceeding 20% weight loss from starting point
- •Dramatic improvements in metabolic health markers
- •New, healthier relationship with food firmly established
- •Side effects minimal or absent at this stage
What's normal
- •Weight loss rate slowing as you approach a new equilibrium
- •Maintained reduced appetite at your dose
- •Lab improvements in blood sugar, cholesterol, liver enzymes, inflammation
- •Complete wardrobe replacements and comments from everyone you know
What's next
- →Continue maintenance therapy—weight typically returns if medication stops
- →Work with your healthcare team on your long-term plan
- →Focus on lifestyle habits that support maintaining your incredible progress
Signs it's working · Appetite and Eating Behavior
- ✓Feeling genuinely full and satisfied with much smaller portions
- ✓Fewer food cravings, especially for sweets, snacks, and junk food
- ✓Reduced 'food noise'—that constant mental chatter about what to eat next
- ✓Naturally gravitating toward healthier food choices
- ✓Ability to stop eating when satisfied without internal struggle
- ✓Less emotional or stress eating
Signs it's working · Weight and Body Composition
- ✓Scale weight consistently trending downward week after week
- ✓Clothes becoming loose, needing smaller sizes
- ✓Visible changes in face shape, waistline, and overall silhouette
- ✓Waist circumference decreasing measurably
- ✓Before/after photos showing obvious transformation
Signs it's working · Metabolic Health (via lab tests)
- ✓Blood sugar levels dropping significantly (HbA1c improving)
- ✓Blood pressure moving toward healthy range
- ✓Cholesterol panel improving—lower LDL, lower triglycerides
- ✓Liver enzymes normalizing if previously elevated
- ✓Inflammatory markers like CRP decreasing
Not seeing results? Common reasons
- •Not at therapeutic dose yet—most weight loss occurs at 10-15mg; lower starting doses are just for adjustment
- •Not giving it enough time—significant results typically require 3-6 months of consistent use at higher doses
- •Eating through the medication—forcing yourself to eat large portions despite feeling full defeats the purpose
- •Choosing calorie-dense foods—even smaller portions of high-calorie foods can stall progress
- •Underlying conditions interfering—thyroid disorders, PCOS, certain medications, or hormonal imbalances may slow results
- •Dehydration affecting the scale—ensure adequate water intake for accurate weight readings
Key research
07 · Questions
Frequently asked
How much weight will I actually lose on tirzepatide?+
Clinical trials showed average weight loss of about 20% of body weight at the highest dose over 72 weeks—that's around 50 pounds for someone starting at 250 pounds. Some people lose even more. Results vary based on starting weight, dose achieved, diet, exercise, and individual factors, but tirzepatide produces the highest average weight loss of any medication ever approved.
How is tirzepatide different from semaglutide (Ozempic/Wegovy)?+
While semaglutide only activates GLP-1 receptors, tirzepatide activates both GLP-1 and GIP receptors. This dual-action approach appears to produce greater appetite suppression and weight loss. Head-to-head trials showed tirzepatide users lost about 5-6 more pounds than semaglutide users. Tirzepatide also produced better blood sugar control in people with diabetes.
Why do I have to increase the dose so slowly?+
The gradual dose escalation (every 4 weeks) is essential for tolerability. Starting at the full 15mg dose would cause severe nausea and vomiting in most people. By slowly ramping up, your GI system adapts, making side effects much more manageable. Patience during this phase leads to better long-term success.
What happens if I stop taking tirzepatide?+
Most people regain significant weight after stopping—studies suggest about two-thirds of lost weight returns within a year. This isn't failure; it's biology. The medication is treating the underlying metabolic and neurological drivers of obesity. When the treatment stops, those drivers return. Most people benefit from long-term maintenance therapy.
Will I lose muscle along with fat?+
Some muscle loss occurs with any significant weight loss, including with tirzepatide—roughly 25-40% of weight lost may be lean mass. To minimize this, prioritize protein (aim for at least 1g per pound of goal body weight), do resistance training regularly, and don't skip meals even if you're not hungry.
Is tirzepatide safe for long-term use?+
Current data from clinical trials extending beyond 72 weeks shows a consistent safety profile. The SURPASS-CVOT trial is studying long-term cardiovascular outcomes. That said, tirzepatide is newer than semaglutide (approved 2022 for diabetes, 2023 for obesity), so long-term monitoring continues. The safety profile is similar to other GLP-1 drugs in the same class.
Why is there a thyroid cancer warning?+
In rodent studies, tirzepatide and similar drugs caused thyroid C-cell tumors. Rodents have many more GIP/GLP-1 receptors in their thyroid than humans. After years of clinical use of this drug class, no clear increase in human thyroid cancer has been observed. Still, tirzepatide is contraindicated if you have a personal or family history of medullary thyroid cancer or MEN2 syndrome.
What's the difference between Mounjaro and Zepbound?+
They're both tirzepatide, just approved for different conditions. Mounjaro is approved for type 2 diabetes. Zepbound is approved for chronic weight management in people with obesity or overweight with weight-related conditions. The dosing and medication are identical—only the indication and branding differ.
08 · Further reading
History & related research
Studied for